Our Projects

Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.

Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.

 

 

Filters / Search

Grant focus
The IMPACT project will develop long-acting injectable ivermectin to fight malaria transmission

Grantees
MedinCell

Status
Current

Amount
US$ 6,358,125

Disease
Malaria

Long-acting medicines for innovative vector control

View More

Grant focus
To bring better pediatric medicines for drug-resistant TB

Grantees
Stellenbosch University (SU)

Status
Current

Amount
US$ 18,926,925

Disease
Tuberculosis

Better treatments and prevention for drug-resistant tuberculosis in children

View More

Grant focus
To transform oral HIV treatment into a long-acting injectable

Grantees
University of Washington

Status
Current

Amount
US$ 6,962,027

Disease
HIV and Co-Infection

Long-acting injections to treat HIV

View More

Grant focus
Bringing secondary prevention of cervical cancer to scale in low- and middle-income countries

Grantees
Expertise France

Status
Current

Amount
US$ 24,322,600

Disease
HIV and Co-Infection

Intensifying and promoting cervical cancer prevention in low-resource countries

View More

Grant focus
To develop long-acting formulations of key medicines and create a market for them

Grantees
University of Liverpool

Status
Current

Amount
US$ 32,004,459

Disease
HIV and Co-Infection, Malaria, Tuberculosis

Long-acting medicines for malaria, tuberculosis and hepatitis C

View More

Grant focus
To pilot targeted next-generation sequencing, an innovation that provides fast, accurate diagnosis of drug-resistant TB

Grantees
Foundation for Innovative New Diagnostics (FIND)

Status
Current

Amount
US$ 14,500,000

Disease
Tuberculosis

High-tech tests for drug-resistant TB

View More

Grant focus
To create affordable solutions for preventing cervical cancer

Grantees
Clinton Health Access Initiative (CHAI)

Status
Current

Amount
US$ 32,958,435

Disease
HIV and Co-Infection

Innovative, affordable screening and treatment to prevent cervical cancer

View More

Grant focus
To harness mobile technology to help patients adhere to their TB medications

Grantees
KNCV Tuberculosis Foundation

Status
Current

Amount
US$ 13,998,007

Disease
Tuberculosis

Smart pillboxes and mobile technology to support TB treatment

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.